PRESTRELSKI STEVEN (Chief Scientific Officer) sold 2.3% of their position (10K shares) of XERIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $55.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/14/2020ACC: 0000899243-20-001167
Officer· Chief Scientific Officer
Since Dec 2018
-10K
Net shares
Net seller
$55.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10K
Price / share
$5.50
Trade value
$54.99K
% of position
2.3%
1/13/2020
431.82K→421.82K
Total
Net shares
−10K
Net value
-$54.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/13/2020 | S · Sale | −10K | $5.50 | $54.99K | 2.3% | 431.82K | 421.82K |
| Total | −10K | -$54.99K | ||||||
Derivative Transactions0
No derivative transactions reported